Nadina’s ambition is to contribute and support the work of teams exploiting exciting therapies and bring these as close to patients as possible.
Over the last 20+ years, moving across pre-clinical and clinical research, and from technical to more strategic roles, she has supported the development of several molecules and diagnostics and overseen clinical, translational, regulatory and CMC aspects, in commercial and public environments.
Since July 2018 she works as an independent consultant involved a variety of R&D projects focusing on pre-IND/ CTA to Phase II/ clinical Proof of Concept stages. Previous roles include, Director of Consultancy (SMS-oncology, NL), Project Leader (uniQure, NL), Research Centre Manager (Biomedical Health Research Centre & Leeds Cancer Research UK Centre, University of Leeds, UK), Translational Science Strategist (AstraZeneca, UK) and Laboratory Head (Novartis, CH).
Nadina has been supporting the EU-funded initiative Remedi4All as a regulatory advisor since its launch in September 2022 and is serving as an Expert Evaluator for European Commission Funding since 2009.